Hyderabad Sep19 PTI The Strategic Advisory Group of Experts on Immunization SAGE of the World health Organisation would be meeting in October to make its recommendations on Bharat Biotechs COVID-19 vaccine Covaxin on Emergency Use Listing Bharat Biotech is expected to give a presentation on the Vaccines safety and efficacy data of clinical trials phase 1-3 trial results and post marketingand Risk management plans and other implementation considerations according to the SAGE draft agenda SAGE is authorised with advising WHO on overall global policies and strategies ranging from vaccines and technology research and development to delivery of immunization and its linkages with other health interventions Hanna Nohynek member of SAGE will be presenting a draft recommendation for the vaccine and the session will make its recommendations The session will thoroughly discuss the clinical data on Covaxin from phase 1 2 3 trials and post marketing studies on safety immunogenicity efficacy and effectiveness besides update on global regional and country level plans for vaccine safety monitoring the agenda said Bharat Biotech recently said it has submitted all the data pertaining to Covaxin to the WHO for EUL and is awaiting feedback from the global health watchdog The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet to be confirmed according to the update available on the WHO website In an update on its website the WHO said it began rolling data of the vaccine on July 6Rolling data allows the WHO to start its review right away as information continues to come in to accelerate the overall review process Covaxin is one of the six vaccines that have received emergency use authorisation from Indias drug regulator and is being used in the nationwide inoculation programme along with Covishield and Sputnik V PTI GDK APR APR